The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Generic Entry and the Pricing of Pharmaceuticals
Open accessAbstract
During the 1980s the share of prescriptions sold by retail pharmacies that was accounted for by generic products roughly doubled. The price response to generic entry of brand‐name products has been a source of controversy. In this paper we estimate models of price responses to generic entry in the market for brand‐name and generic drugs. We study a sample of 32 drugs that lost patent protection during the early to mid‐1980s. Our results provide evidence that brand‐name prices increase after generic entry and are accompanied by large decreases in the price of generic drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act
Grabowski, H. G., & Vernon, J. M. (1992) · The Journal of Law and Economics · doi:10.1086/467257 · Cited by 574
Cited by
Pricing in the Market for Anticancer Drugs
Howard, D. H., Bach, P. B., Berndt, E. R., & Conti, R. M. (2015) · Journal of Economic Perspectives · doi:10.1257/jep.29.1.139 · Cited by 444
Uncertainty and Learning in Pharmaceutical Demand
Crawford, G. S., & Shum, M. (2005) · Econometrica · doi:10.1111/j.1468-0262.2005.00612.x · Cited by 433
Indexing and active fund management: International evidence
Cremers, M., Ferreira, M. A., Matos, P., & Starks, L. (2016) · Journal of Financial Economics · doi:10.1016/j.jfineco.2016.02.008 · Cited by 338
Threat of platform‐owner entry and complementor responses: Evidence from the mobile app market
Wen, W., & Zhu, F. (2019) · Strategic Management Journal · doi:10.1002/smj.3031 · Cited by 315
Generic Drug Industry Dynamics
Reiffen, D., & Ward, M. R. (2005) · Review of Economics and Statistics · doi:10.1162/0034653053327694 · Cited by 312
Metadata
- Authors
- Frank, R. G., & Salkever, D. S.
- Venue
- Journal of Economics & Management Strategy
- Publisher
- Wiley
- Published
- 1997-03
- Volume
- 6
- Issue
- 1
- Pages
- 75-90
- ISSN
- 1058-6407 (ISSN-L)
- 1530-9134
- OpenAlex
- W2096536539
- Cited by
- 374
- References
- 1
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Generic Entry and the Pricing of Pharmaceuticals. https://app.cochat.ai/papers/10.1111/j.1430-9134.1997.00075.x
- The paper
- Frank, R. G., & Salkever, D. S. (1997). Generic Entry and the Pricing of Pharmaceuticals. Journal of Economics & Management Strategy. https://doi.org/10.1111/j.1430-9134.1997.00075.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.